Consider reading these articles
HLTH 2024 reinforced many of the key market themes our team is excited about, validating our approach to supporting founders positioned at the intersection of technology and healthcare. Here are four core themes shaping healthcare transformation.
Market Perspective
We're focused on backing founders building AI technologies that unlock efficiencies, reduce costs, and enable precision in healthcare workflows. With substantial interest in AI-driven tools, especially those that address critical operational bottlenecks, we see a unique opportunity for solutions that balance innovation with usability in complex healthcare settings.
Observations at HLTH 2024
HLTH highlighted a growing disparity between early AI adopters and incumbents needing external support. Companies like Lilly and Amgen demonstrated impressive gains—Lilly saved 1.4M hours by applying AI to drug development, while Amgen used AI to halve the time to market for new drugs by optimizing clinical trial site selection.
However, only half of the healthcare industry has adopted the foundational cloud services needed to leverage data for AI models. This has led to significant point solution fatigue, particularly among payers. Notable partnerships like Highmark Health's integration with Google Cloud and Epic demonstrate the growing preference for unified platform solutions that can advance data sharing and care coordination. Our portfolio company, Vivid Health, exemplifies this trend by leveraging Provider Led AI™ to transform post-acute and home health care. Their platform accelerates documentation, automates pre-visit care plans, and streamlines follow-up with patients, enabling providers to efficiently deliver personalized care at scale while addressing labor challenges in home-based care settings. Similarly, Latitude, a company backed by Redesign, demonstrates how AI can transform core healthcare processes. They leverage AI to modernize utilization management workflows for health plans—enabling faster, more accurate clinical decisions while delivering immediate ROI.
The explosive growth in GenAI vendors and use cases from HLTH 2023 to 2024 underscores that we're witnessing just the tip of the iceberg in the "AI generation" of software solutions. Enterprise customers emphasized the need for well-articulated strategies across two critical areas. The first is testing and rating LLM accuracy regularly with users outside their core customer base—particularly crucial given relatively low barriers to entry for GenAI companies. The second is supporting end-to-end change management, as leaders emphasized that entire workforces—up to the CEO—will need upskilling to realize AI's true value. A high-performing LLM is useless without a rock-solid change management strategy.
"Only half of the healthcare industry has adopted the foundational cloud services needed to leverage data for AI models, leading to significant point solution fatigue."
Opportunity Zone: Where We See Potential
We want to partner with founders who both address incumbents' simultaneous AI appetite and point solution fatigue head-on, including:
Market Perspective
The demand for workforce optimization technologies in healthcare is undeniable, especially as nursing shortages, turnover, and burnout become increasingly acute. We are focused on founders who empower healthcare workers, streamline administrative tasks, and create sustainable workforce solutions.
Observations at HLTH 2024
The conference's dedicated Nurse Pavilion highlighted critical challenges in the nursing workforce, including administrative overload and opportunities to accelerate the shift to value-based care. Early innovators like In-House Health demonstrated the potential for AI-driven scheduling platforms, but the opportunity extends far beyond basic automation. We've seen this need firsthand through our portfolio company Stitch PEO, which is helping independent medical practices optimize their workforce management through a purpose-built PEO that handles everything from benefits and payroll to scheduling and compliance, allowing healthcare providers to focus on patient care. Similarly, our portfolio company Iolite uses AI-powered analytics to help provider organizations boost clinician engagement and performance through data-driven guidance and early warning systems for clinician performance.
"The demand for workforce optimization technologies in healthcare is undeniable, especially as nursing shortages, turnover, and burnout become increasingly acute."
Opportunity Zone: Where We See Potential
We're particularly interested in founders building solutions that are:
Market Perspective
We're excited about founders who can bridge the gap between treatment-focused models and holistic, preventive approaches. Despite high levels of primary care access and the push toward value-based care, preventive strategies remain underutilized.
Observations at HLTH 2024
HLTH 2024 doubled down on wellness themes, particularly Food as Medicine and its role in holistic prevention strategies. Leaders highlighted successful preventive medicine businesses, such as home testing and whole-body MRI companies, that have achieved rapid growth through direct-to-consumer, cash-pay approaches.
"Despite high levels of primary care access and the push toward value-based care, preventive strategies remain underutilized."
Opportunity Zone: Where We See Potential
The market is ready for new businesses that are:
Market Perspective
We're focused on backing founders who are addressing historically underserved areas in women's health, particularly those that can translate new research into scalable, accessible solutions.
Observations at HLTH 2024
First Lady Dr. Jill Biden's announcement of $110M in funding for women's health research marks a significant milestone. This initiative will support research into understudied conditions such as endometriosis and menopause, while developing new methodologies for assessing women's pain levels during procedures.
"Women's health needs are frequently underserved by general healthcare platforms, leading to gaps in care."
Opportunity Zone: Where We See Potential
We believe this research will create significant momentum for the next generation of women's health companies. We're particularly interested in founders who are focused on:
As we transition into 2025 and beyond, we plan to double down on these transformative themes. We remain committed to redesigning healthcare for all by embracing AI innovation, workforce empowerment, preventive care, and women's health, all while building companies that can scale rapidly for maximum long-term impact.